GAPDH has been stated as a reference marker of global cellularity when normalized to the recovery of CD45 as a marker of the non-specific isolated lymphocytes11, herein demonstrating the presence of an additional population in advanced NSCLC patients (p < 0.001; Fig. 1a). The gene discussed is GAPDH; the disease is non-small cell lung carcinoma.